Skip to content
Home/Companies/Biotech/Officinae Bio
Officinae Bio

Officinae Bio

Biotech·Italy·Exited 2025·Held 4yr
Entry
2021
Hold
4yr
Exit
2025

Who owns Officinae Bio?

Officinae Bio is an Italian Biotech company, now owned by Maravai LifeSciences, which acquired it in 2025 from Nucleus Capital.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Nucleus Capital
Investor
Nucleus Capital
Nucleus Capital I · 2021 · VC

Key facts

HQItaly
SectorBiotech
StatusAcquired
Websiteofficinae.bio
Exit Type
Trade Sale
Buyer
Maravai LifeSciences
Exit Year
2025

More from Nucleus Capital I

Other portfolio companies in the same fund.

atmio
Active
ClimateTechGermany· 2023
Biographica
Biographica
Active
BiotechUK· 2023
Biomia
Biomia
Active
BiotechDenmark· 2023
Brineworks
Brineworks
Active
ClimateTechNetherlands· 2023
Endolith
Endolith
Active
IndustrialsUS· 2023
Farmless
Farmless
Active
FoodTechNetherlands· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Officinae Bio?

Officinae Bio is now owned by Maravai LifeSciences, which acquired it in 2025 from Nucleus Capital.

When did Maravai LifeSciences acquire Officinae Bio?

Maravai LifeSciences acquired Officinae Bio in 2025, buying from Nucleus Capital.

Who did Officinae Bio sell to?

Nucleus Capital sold Officinae Bio to Maravai LifeSciences in 2025 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue